Analgesic Effect of Tuina on Rat Models with Compression of the Dorsal Root Ganglion Pain
July 14th, 2023
This article presents a manipulation for treating chronic compression of the dorsal root ganglion in rats using Tuina therapy, along with a method for evaluating its effectiveness based on pain behavior and histopathological results.
Tuina analgesia is widely used in clinical practice. Our research focuses on the mechanism of action of Tuina analgesia and investigate how Tuina achieve its analgesic effect. Achieving standardization in Trina is currently the most significant obstacle.
The effectiveness of Tuina is influenced by several factors, such as treatment area, type, intensity, and frequency. The current protocol is optimized in two aspects based on the earlier research. Firstly, the force and frequency are pushing and holding operations were standouts and controlled by force smashing glows.
Secondly, the results of imaging and animal behavior tests were integrated to assess the results of modeling. To establish the animal model, start by securing an anesthetized rat on a foam board, fastening its limbs and incisors using rubber bands. Wipe the prepared area with a 75%alcohol swab.
Next, use scissors to make a two to three centimeter incision through the skin, superficial fascia, and deep fascia layer by layer. Locate the anterior superior iliac spine, followed by the third and fourth spinous processes. Clamp the spinous process with toothed forceps, and lift it to allow the scissors to be close to the right side of the spinous process.
Cut the muscle attached to the right side of the spinous process. Then, bluntly dissect the muscle attached to the outer surface of the vertebral plate until resistance is felt. Similarly, bluntly dissect the muscle and fascia on the zygapophysial joint.
Use an L-shaped probe to locate the intervertebral foramen. Next, insert an L-shaped stainless steel rod into the fourth and fifth lumbar intervertebral foramen. Proceed to suture the muscle, fascia, and skin layer by layer using 3-0 sutures.
Place the rat in a thermostatic box until it wakes up, and observe the function of the rat's right hind limb to ensure normalcy. To standardize the Tuina therapy, first practice Tunia using the finger sleeve's feedback data, adjusting force to five newtons and frequency to two hertz. Next, perform Tuina on immobilized rats, maintaining consistent force and frequency.
Identify the acupoint by selecting the gastrocnemius muscle of the right hind limb at the junction of its two heads, approximately at BL57. Perform the Tuina by positioning the thumb vertically on the BL57 acupoint and moving in rhythmic small range rotary motions, exerting five newtons of pressure. After 17 days of Tuina therapy, a significant difference was observed in paw withdrawal thresholds between the CCD rats receiving Tuina therapy and the untreated CCD group.
The rats in the CCD group receiving Tuina therapy showed improvement in pain threshold from the beginning of treatment. Thermal pain thresholds differed significantly between the CCD group and the Tuina group from day 14. To conduct the Von Frey test, begin by placing the rats in a transparent tempered glass compartment on a metal wire grid stand at a height of 40 centimeters.
Next, measure the mechanical withdrawal threshold with Von Frey electronic fibers. Stimulate the rat's foot until it reacts noticeably, such as by lifting the leg or avoiding it. To assess the paw withdrawal latency or PWL using the Hargreaves method, focus the spotlight on the center of the rat's foot and press the Start button.
Monitor the rat for behaviors, such as foot retraction or paw licking, and press the Start button again to record the time. Perform the test on the same hind limb three consecutive times. After 17 days of Tuina therapy, a significant difference was observed in paw withdrawal thresholds between the CCD rats receiving Tuina therapy and the untreated CCD group.
The rats in the CCD group receiving Tuina therapy showed improvement in pain threshold from the beginning of treatment. Thermal pain thresholds differed significantly between the CCD group and the Tuina group from day 14.
View the full transcript and gain access to thousands of scientific videos
Overview
This article presents a manipulation for treating chronic compression of the dorsal root ganglion in rats using Tuina therapy, along with a method for evaluating its effectiveness based on pain behavior and histopathological results.
Key Study Components
Area of Science
- Neuroscience
- Pain Management
- Therapeutic Techniques
Background
- Tuina analgesia is widely used in clinical practice.
- The mechanism of action of Tuina analgesia is not fully understood.
- Standardization in Tuina therapy presents significant challenges.
- Effectiveness is influenced by treatment area, type, intensity, and frequency.
Purpose of Study
- To investigate the analgesic effect of Tuina therapy.
- To evaluate the effectiveness of Tuina in treating chronic pain.
- To optimize the protocol for Tuina therapy based on previous research.
Methods Used
- Manipulation of the dorsal root ganglion in rats.
- Assessment of pain behavior.
- Histopathological evaluation of results.
- Control of force and frequency during Tuina application.
Main Results
- Tuina therapy demonstrated effectiveness in reducing pain behavior.
- Histopathological results supported the analgesic effects observed.
- Optimized protocol improved treatment outcomes.
- Standardization challenges were highlighted.
Conclusions
- Tuina therapy is a viable option for treating chronic pain.
- Further research is needed to standardize treatment protocols.
- Understanding the mechanisms of Tuina can enhance its clinical application.
Frequently Asked Questions
Executive Industry Relevance
Standardized animal models for neuropathic pain are critical for de-risking early analgesic discovery and clarifying mechanistic hypotheses. This protocol enables reproducible evaluation of Tuina's analgesic effects using quantitative behavioral and histopathological endpoints, supporting predictive confidence in target validation. The approach strengthens translational continuity from preclinical pain models to potential therapeutic development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of analgesic mechanisms in a controlled, disease-relevant system.
- Supports functional target validation by linking intervention to quantifiable pain thresholds.
- Facilitates biological de-risking through standardized manipulation and outcome measurement.
- Provides a platform for hypothesis-driven evaluation of novel pain modulators.
Screening & Assay Development
- Delivers validated behavioral assays (Von Frey, Hargreaves) for quantitative pain assessment.
- Standardizes force and frequency parameters to ensure reproducibility across studies.
- Enables reliable comparison of intervention effects in preclinical screening workflows.
- Supports assay scalability and cross-study data integration.
Translational & Preclinical Research
- Aligns preclinical endpoints with clinically relevant pain phenotypes.
- Provides continuity from mechanistic studies to translational biomarker development.
- Informs risk-adjusted advancement of analgesic candidates based on robust preclinical data.
- Strengthens predictive value for downstream therapeutic evaluation.
Pipeline & Workflow Integration
This protocol positions standardized Tuina intervention and pain assessment within the early discovery to preclinical validation continuum for neuropathic pain research.
- Discovery Biology: Supports hypothesis testing on analgesic mechanisms and pathway involvement using controlled DRG compression models.
- Screening: Provides reproducible, quantitative behavioral assays for evaluating intervention efficacy.
- Analytics: Integrates behavioral and histopathological readouts for robust statistical comparison of treatment groups.
- Translational Research: Bridges preclinical findings to clinical pain endpoints through disease-relevant modeling.
- Enterprise Reuse: Establishes a reusable, standardized platform for analgesic research across discovery programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in analgesic target validation.
- Operational Value: Enhances reproducibility and standardization of pain assessment protocols.
- Strategic Value: Improves go/no-go decision quality and capital efficiency in early-stage analgesic portfolios.
- Portfolio Impact: Enables risk-adjusted prioritization of pain therapeutic candidates based on robust preclinical evidence.
Implementation Considerations
- Requires expertise in rodent surgical modeling and behavioral pain assays.
- Demands precise instrumentation for force and frequency control during Tuina application.
- Necessitates cross-team standardization of behavioral and histopathological endpoints.
- Adaptation to other neuropathic pain models may require protocol optimization.
- Limitations include model-specific relevance and the need for further mechanistic elucidation.
